Literature DB >> 28031563

Prostate cancer: Risk factors - you find what you are looking for.

Christopher J D Wallis1, Raj Satkunasivam2.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2016        PMID： 28031563     DOI： 10.1038/nrurol.2016.267

Source DB:  PubMed          Journal:  Nat Rev Urol        ISSN： 1759-4812            Impact factor:   14.432


× No keyword cloud information.
  2 in total

1.  Intravenous delivery of enzalutamide based on high drug loading multifunctional graphene oxide nanoparticles for castration-resistant prostate cancer therapy.

Authors:  Wenjun Jiang; Jiyuan Chen; Chunai Gong; Yuanyuan Wang; Yuan Gao; Yongfang Yuan
Journal:  J Nanobiotechnology       Date:  2020-03-18       Impact factor: 10.435

2.  LOC100996425 acts as a promoter in prostate cancer by mediating hepatocyte nuclear factor 4A and the AMPK/mTOR pathway.

Authors:  Xiuyan Wang; Bin Song; Mingcui Zang; He Ji; He Yang; Shuang Jiang; Xiao Yang
Journal:  J Cell Mol Med       Date:  2021-07-26       Impact factor: 5.310
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.